Further, since inflammation of various levels has often been associated with tumor development (148), and ICAM-1 expression is up-regulated in lymphatic vessels during inflammation (94), interaction between Mac-1 and ICAM-1 expressed on DCs and inflamed lymphatic endothelium, respectively, may lead to decreased ability of DCs to activate T cells (87). Here, ITGB2 is linked to neoplasm.